CJC-1295 No-DAC vs Somatropin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
CJC-1295 No-DAC (also called Modified GRF 1-29 or Mod GRF) is a short-acting GHRH (Growth Hormone-Releasing Hormone) analog consisting of the first 29 amino acids of endogenous GHRH with four amino acid substitutions to improve stability and receptor binding....
Calculate CJC-1295 No-DAC dose →Somatropin is recombinant human growth hormone (rhGH) - a 191 amino acid protein identical to endogenous pituitary GH, produced via recombinant DNA technology. It is FDA-approved for multiple indications including pediatric and adult growth hormone deficiency, Turner syndrome, HI...
Calculate Somatropin dose →| Parameter | CJC-1295 No-DAC | Somatropin |
|---|---|---|
| Category | Growth Hormone & IGF | Growth Hormone & IGF |
| Research | Research Use | FDA Approved |
| Half-Life | 30 minutes | ~3–4 hours (SubQ); ~20 min (IV) |
| Typical Dose | 100–200 µg | 0.1–0.3 mg/day (GHD); up to 2 mg/day (clinical indications) |
| Frequency | 2–3x daily | Daily or 6 days/week |
| Route | Subcutaneous | Subcutaneous / Intramuscular |
| FDA Status | Not Approved | Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.